Cost saving analysis of specialized, eHealth-based management of patients receiving oral anticoagulation therapy: Results from the thrombEVAL study

Abstract To evaluate the cost-saving of a specialized, eHealth-based management service (CS) in comparison to regular medical care (RMC) for the management of patients receiving oral anticoagulation (OAC) therapy. Costs of hospitalization were derived via diagnosis-related groups which comprise diag...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Lisa Eggebrecht, Paul Ludolph, Sebastian Göbel, Marina Panova-Noeva, Natalie Arnold, Markus Nagler, Christoph Bickel, Michael Lauterbach, Roland Hardt, Hugo ten Cate, Karl J. Lackner, Christine Espinola-Klein, Thomas Münzel, Jürgen H. Prochaska, Philipp S. Wild
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/66248d79035f4c89b8fc80edb096ea0d
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:66248d79035f4c89b8fc80edb096ea0d
record_format	dspace
spelling	oai:doaj.org-article:66248d79035f4c89b8fc80edb096ea0d2021-12-02T14:16:58ZCost saving analysis of specialized, eHealth-based management of patients receiving oral anticoagulation therapy: Results from the thrombEVAL study10.1038/s41598-021-82076-92045-2322https://doaj.org/article/66248d79035f4c89b8fc80edb096ea0d2021-01-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-82076-9https://doaj.org/toc/2045-2322Abstract To evaluate the cost-saving of a specialized, eHealth-based management service (CS) in comparison to regular medical care (RMC) for the management of patients receiving oral anticoagulation (OAC) therapy. Costs of hospitalization were derived via diagnosis-related groups which comprise diagnoses (ICD-10) and operation and procedure classification system (OPS), which resulted in OAC-related (i.e. bleeding/ thromboembolic events) and non-OAC-related costs for both cohorts. Cost for anticoagulation management comprised INR-testing, personnel, and technical support. In total, 705 patients were managed by CS and 1490 patients received RMC. The number of hospital stays was significantly lower in the CS cohort compared to RMC (CS: 23.4/100 py; RMC: 68.7/100 py); with the most pronounced difference in OAC-related admissions (CS: 2.8/100 py; RMC: 13.3/100 py). Total costs for anticoagulation management amounted to 101 EUR/py in RMC and 311 EUR/py in CS, whereas hospitalization costs were 3261 [IQR 2857–3689] EUR/py in RMC and 683 [504–874] EUR/py in CS. This resulted in an overall cost saving 2368 EUR/py favoring the CS. The lower frequency of adverse events in anticoagulated patients managed by the telemedicine-based CS compared to RMC translated into a substantial cost-saving, despite higher costs for the specialized management of patients. Trial registration: ClinicalTrials.gov, unique identifier NCT01809015, March 8, 2013.Lisa EggebrechtPaul LudolphSebastian GöbelMarina Panova-NoevaNatalie ArnoldMarkus NaglerChristoph BickelMichael LauterbachRoland HardtHugo ten CateKarl J. LacknerChristine Espinola-KleinThomas MünzelJürgen H. ProchaskaPhilipp S. WildNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Lisa Eggebrecht Paul Ludolph Sebastian Göbel Marina Panova-Noeva Natalie Arnold Markus Nagler Christoph Bickel Michael Lauterbach Roland Hardt Hugo ten Cate Karl J. Lackner Christine Espinola-Klein Thomas Münzel Jürgen H. Prochaska Philipp S. Wild Cost saving analysis of specialized, eHealth-based management of patients receiving oral anticoagulation therapy: Results from the thrombEVAL study
description	Abstract To evaluate the cost-saving of a specialized, eHealth-based management service (CS) in comparison to regular medical care (RMC) for the management of patients receiving oral anticoagulation (OAC) therapy. Costs of hospitalization were derived via diagnosis-related groups which comprise diagnoses (ICD-10) and operation and procedure classification system (OPS), which resulted in OAC-related (i.e. bleeding/ thromboembolic events) and non-OAC-related costs for both cohorts. Cost for anticoagulation management comprised INR-testing, personnel, and technical support. In total, 705 patients were managed by CS and 1490 patients received RMC. The number of hospital stays was significantly lower in the CS cohort compared to RMC (CS: 23.4/100 py; RMC: 68.7/100 py); with the most pronounced difference in OAC-related admissions (CS: 2.8/100 py; RMC: 13.3/100 py). Total costs for anticoagulation management amounted to 101 EUR/py in RMC and 311 EUR/py in CS, whereas hospitalization costs were 3261 [IQR 2857–3689] EUR/py in RMC and 683 [504–874] EUR/py in CS. This resulted in an overall cost saving 2368 EUR/py favoring the CS. The lower frequency of adverse events in anticoagulated patients managed by the telemedicine-based CS compared to RMC translated into a substantial cost-saving, despite higher costs for the specialized management of patients. Trial registration: ClinicalTrials.gov, unique identifier NCT01809015, March 8, 2013.
format	article
author	Lisa Eggebrecht Paul Ludolph Sebastian Göbel Marina Panova-Noeva Natalie Arnold Markus Nagler Christoph Bickel Michael Lauterbach Roland Hardt Hugo ten Cate Karl J. Lackner Christine Espinola-Klein Thomas Münzel Jürgen H. Prochaska Philipp S. Wild
author_facet	Lisa Eggebrecht Paul Ludolph Sebastian Göbel Marina Panova-Noeva Natalie Arnold Markus Nagler Christoph Bickel Michael Lauterbach Roland Hardt Hugo ten Cate Karl J. Lackner Christine Espinola-Klein Thomas Münzel Jürgen H. Prochaska Philipp S. Wild
author_sort	Lisa Eggebrecht
title	Cost saving analysis of specialized, eHealth-based management of patients receiving oral anticoagulation therapy: Results from the thrombEVAL study
title_short	Cost saving analysis of specialized, eHealth-based management of patients receiving oral anticoagulation therapy: Results from the thrombEVAL study
title_full	Cost saving analysis of specialized, eHealth-based management of patients receiving oral anticoagulation therapy: Results from the thrombEVAL study
title_fullStr	Cost saving analysis of specialized, eHealth-based management of patients receiving oral anticoagulation therapy: Results from the thrombEVAL study
title_full_unstemmed	Cost saving analysis of specialized, eHealth-based management of patients receiving oral anticoagulation therapy: Results from the thrombEVAL study
title_sort	cost saving analysis of specialized, ehealth-based management of patients receiving oral anticoagulation therapy: results from the thrombeval study
publisher	Nature Portfolio
publishDate	2021
url	https://doaj.org/article/66248d79035f4c89b8fc80edb096ea0d
work_keys_str_mv	AT lisaeggebrecht costsavinganalysisofspecializedehealthbasedmanagementofpatientsreceivingoralanticoagulationtherapyresultsfromthethrombevalstudy AT paulludolph costsavinganalysisofspecializedehealthbasedmanagementofpatientsreceivingoralanticoagulationtherapyresultsfromthethrombevalstudy AT sebastiangobel costsavinganalysisofspecializedehealthbasedmanagementofpatientsreceivingoralanticoagulationtherapyresultsfromthethrombevalstudy AT marinapanovanoeva costsavinganalysisofspecializedehealthbasedmanagementofpatientsreceivingoralanticoagulationtherapyresultsfromthethrombevalstudy AT nataliearnold costsavinganalysisofspecializedehealthbasedmanagementofpatientsreceivingoralanticoagulationtherapyresultsfromthethrombevalstudy AT markusnagler costsavinganalysisofspecializedehealthbasedmanagementofpatientsreceivingoralanticoagulationtherapyresultsfromthethrombevalstudy AT christophbickel costsavinganalysisofspecializedehealthbasedmanagementofpatientsreceivingoralanticoagulationtherapyresultsfromthethrombevalstudy AT michaellauterbach costsavinganalysisofspecializedehealthbasedmanagementofpatientsreceivingoralanticoagulationtherapyresultsfromthethrombevalstudy AT rolandhardt costsavinganalysisofspecializedehealthbasedmanagementofpatientsreceivingoralanticoagulationtherapyresultsfromthethrombevalstudy AT hugotencate costsavinganalysisofspecializedehealthbasedmanagementofpatientsreceivingoralanticoagulationtherapyresultsfromthethrombevalstudy AT karljlackner costsavinganalysisofspecializedehealthbasedmanagementofpatientsreceivingoralanticoagulationtherapyresultsfromthethrombevalstudy AT christineespinolaklein costsavinganalysisofspecializedehealthbasedmanagementofpatientsreceivingoralanticoagulationtherapyresultsfromthethrombevalstudy AT thomasmunzel costsavinganalysisofspecializedehealthbasedmanagementofpatientsreceivingoralanticoagulationtherapyresultsfromthethrombevalstudy AT jurgenhprochaska costsavinganalysisofspecializedehealthbasedmanagementofpatientsreceivingoralanticoagulationtherapyresultsfromthethrombevalstudy AT philippswild costsavinganalysisofspecializedehealthbasedmanagementofpatientsreceivingoralanticoagulationtherapyresultsfromthethrombevalstudy
_version_	1718391609938149376

Cost saving analysis of specialized, eHealth-based management of patients receiving oral anticoagulation therapy: Results from the thrombEVAL study

Ejemplares similares